COMMUNIQUÉS West-GlobeNewswire

argenx to Present at JMP Securities Life Sciences Conference
13/06/2017
June 13, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Biocartis Group NV: Biocartis launches CE-marked IVD test for lung cancer
13/06/2017
PRESS RELEASE: 13 June 2017, 07:00 CEST Biocartis launches CE-marked IVD test for lung cancer Idylla(TM) EGFR Mutation Test is the only on market fully automated CE-IVD test detecting all relevant EGFR mutations [...]
TiGenix Launches Global Phase III Trial for Cx601
13/06/2017
PRESS RELEASE TiGenix Launches Global Phase III Trial for Cx601 Leuven (BELGIUM) - June 13, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting [...]
Tresiba® demonstrated no increased risk of major cardiovascular events and significant reduction in rates of severe hypoglycaemia compared to insulin glargine U100 in the DEVOTE trial
12/06/2017
San Diego, US, 12 June 2017 - Novo Nordisk today announced the primary results from DEVOTE - the first randomised, double-blind, treat-to-target, event-driven trial comparing two basal insulins, Tresiba ® (insulin [...]
ProLynx présente PLX039, un système d'administration de médicament sous forme de microsphères d'hydrogel impliquant la prise mensuelle unique d'un agoniste de récepteur GLP 1
12/06/2017
SAN FRANCISCO, le 12 juin 2017 (GLOBE NEWSWIRE) - Dans un abrégé de dernière minute, lors du 77 e congrès de l'American Diabetes Association à San Diego, ProLynx LLC a présenté un nouveau système d'administration de [...]
Silmäasema Oyj: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act
12/06/2017
Silmäasema Oyj: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act Stock Exchange Release 12 June 2017, at 9.15 p.m. Silmäasema Oyj (the "Company") has today [...]
XBiotech annonce l'interruption de l'étude de phase III pour le cancer colorectal sur la base de la deuxième analyse intermédiaire
12/06/2017
AUSTIN, Texas, le 9 juin 2017 (GLOBE NEWSWIRE) - XBiotech Inc. (NASDAQ:XBIT) a annoncé aujourd'hui qu'un Comité indépendant de surveillance et de suivi des données (IDMC) a réalisé une analyse prospective sans insu de l [...]
Ossur Hf : Transactions in relation to share buyback program
12/06/2017
Announcement from Össur hf. No. 44/2017 Reykjavík, 12 June 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]
Diaxonhit : Nomination de Jean-Michel Carle Grandmougin en tant que Président du directoire
12/06/2017
Nomination de Jean-Michel Carle Grandmougin en tant que Président du directoire de Diaxonhit Paris, France - 12 juin 2017 - DIAXONHIT (FR0004054427, ALEHT, éligible PEA-PME), groupe français leader dans le diagnostic [...]
Solon Eiendom ASA - Primary insider notification
12/06/2017
SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 12 June 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company [...]
Nature Medicine Reports Elimination of Large Tumors in Mice by Messenger RNA-Encoded Bispecific Antibodies
12/06/2017
Novel mRNA-based antibody drug class holds promise for fast development of potent immunotherapies MAINZ, Germany, June 12, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully-integrated biotechnology company pioneering [...]
Prothena Announces Appointment of Wagner Zago, PhD as Chief Scientific Officer
12/06/2017
DUBLIN, Ireland, June 12, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]
ProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist
12/06/2017
SAN FRANCISCO, June 12, 2017 (GLOBE NEWSWIRE) -- In a late-breaking abstract at the 77 th American Diabetes Association meeting in San Diego, ProLynx LLC announced a novel drug delivery system to support once-monthly [...]
Solon Eiendom ASA : Bionor Pharma winding down operations
12/06/2017
Oslo, June 12, 2017 As previously communicated, the biopharmaceutical division engaged a team of international industry experts to propose an updated development plan and strategic partnership assessment. The team has [...]
Saniona AB: Saniona publishes prospectus for listing of shares on Nasdaq Stockholm
12/06/2017
PRESS RELEASE 12 June 2017 Saniona AB (publ) ("Saniona" or the "Company") has prepared a prospectus for admission to trading of the Company's shares at Nasdaq Stockholm. Last day of trading at Nasdaq First North Premier [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
12/06/2017
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
12/06/2017
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
12/06/2017
FIT Biotech Oy Company release June 12, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Zealand to regain control of elsiglutide
12/06/2017
Zealand to regain control of elsiglutide Helsinn returns elsiglutide to Zealand Zealand now has full rights to develop products within cancer-supportive care Lugano, Switzerland and Copenhagen, Denmark, June 12, 2017 - [...]

Pages